相关实验视频

Updated: Jun 3, 2025

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

细胞癌对cuproptosis的敏感性:生物信息学分析和实验验证

Hongfang Li¹, Chanjuan Zhang¹, Neng Zhu²

¹Laboratory of Stem Cell Regulation with Chinese Medicine and Its Application, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.

Journal of Cancer

|January 9, 2025

概括

向细胞死亡过程 - - 型亡,对清细胞细胞癌 (ccRCC) 显示出前景. FDX1和DLAT基因的低表达表明生存率差,并建议ccRCC的新治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症治疗方法癌症治疗方法

背景情况:

质亡是各种癌症的新兴治疗点.
在清细胞细胞癌 (ccRCC) 中,cuproptosis的作用尚不清楚.
确定ccRCC的新型治疗策略至关重要.

研究的目的:

为了研究ccRCC对cuproptosis的敏感性.
探索ccRCC中cuproptosis的潜在分子机制.
为了确定ccRCC治疗的潜在治疗点.

主要方法:

使用公共数据集 (GSE53757,GSE66272) 对与cuproptosis相关的基因的差异基因表达分析.
在体外实验评估 cuproptosis 诱导剂对ccRCC 细胞系的影响.
生物信息分析包括生存分析,基因相关性和途径丰富.
对基因甲基化,免疫透和分子对接的分析.

主要成果:

埃莱斯克洛莫尔是一种cuproptosis诱导剂,在ccRCC细胞系 (786-O,A498) 中显著降低了活力.
在ccRCC中,FDX1和DLAT表达显著低,与预后差和整体存活相关.
功能性丰富分析强调了乙-CoA代谢过程的参与.
FDX1和DLAT表达与免疫透和检查点相关;确定了潜在的药物点.

结论:

ccRCC对 cuproptosis 诱导非常敏感.
针对FDX1和DLAT的组合,为ccRCC提供了一个新的治疗策略.
对FDX1和DLAT作为治疗点的进一步研究可能会导致新的ccRCC治疗方法.

关键词:

清细胞脏细胞癌.这种疾病叫做cuproptosis.DLAT DLAT 这是一个很好的方法.在FDX1上.

更多相关视频

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

相关概念视频

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...